Bolt Biotherapeutics, Inc.

BOLT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Oct 23, 2026 8-K
8-K Oct 6, 2026 8-K
4 Sep 21, 2026 4
4 Sep 21, 2026 4
4 Sep 21, 2026 4
SCHEDULE 13G Aug 13, 2026
10-Q Aug 11, 2026 10-Q
8-K Aug 11, 2026 8-K
4 Jun 11, 2026 4
4 Jun 11, 2026 4
4 Jun 11, 2026 4
4 Jun 11, 2026 4
4 Jun 11, 2026 4
8-K Jun 11, 2026 8-K
10-Q May 12, 2026 10-Q
8-K May 12, 2026 8-K
ARS Apr 28, 2026 ARS
DEFA14A Apr 28, 2026 DEFA14A
DEF 14A Apr 28, 2026 DEF 14A
S-8 Mar 12, 2026 S-8
10-K Mar 12, 2026 10-K
8-K Mar 12, 2026 8-K
SCHEDULE 13D/A Feb 26, 2026
SCHEDULE 13D/A Feb 17, 2026
SCHEDULE 13G/A Feb 13, 2026
← Newer Page 1 of 12 · 292 filings Older →